The Journal of investigative dermatology
-
J. Invest. Dermatol. · May 2012
Letter Randomized Controlled TrialOral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials.
J. Invest. Dermatol. · May 2012